Clinical Trial Update: The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

View source ↗

Summary

This update provides information on the ongoing long-term safety study of Idursulfase-beta in patients with Hunter syndrome (Mucopolysaccharidosis II).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Idursulfase-beta (idursulfase-beta)

Snippet

Sponsor: Green Cross Corporation | Conditions: Hunter Syndrome | Status: UNKNOWN